Is Enliven Therapeutics, Inc. technically bullish or bearish?

As of 26 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by weekly and monthly MACD readings both indicating bearish momentum, alongside a bearish monthly Bollinger Band. The daily moving averages also reflect a mildly bearish trend. The KST and OBV indicators are mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish trend on the weekly timeframe with no trend on the monthly.
In terms of performance, the stock has returned 5.54% over the past week, outperforming the S&P 500, which declined by 0.31%. However, over the longer term, the stock has underperformed significantly, with a year-to-date return of -11.07% compared to the S&P 500's 12.96%, and a one-year return of -17.04% versus the S&P 500's 15.64%.